Update on Isotretinoin and the iPLEDGE System - U.S. Pharmacist
https://www.uspharmacist.com/article/update-on-isotretinoin-and-the-ipledge-system
WebApr 17, 2007 · In order to reduce fetal exposure to isotretinoin, the FDA approved iPLEDGE, a risk management program to regulate the use of isotretinoin, on March 1, 2006. iPLEDGE replaced the manufacturer-initiated SMART (System to Manage Accutane Related Teratogenicity) program and is now the only way pharmacists can dispense isotretinoin.
DA: 11 PA: 68 MOZ Rank: 84